
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $6.32B+9.2% | $5.79B+31.4% | $4.40B+7.5% | $4.10B+27.6% | $3.21B |
| Cost of revenue | $3.70B+10.8% | $3.34B+31.2% | $2.54B+4.4% | $2.44B+43.1% | $1.70B |
| Operations and support | $478.3M+7.8% | $443.8M+3.9% | $427.2M-3.7% | $443.8M+10.3% | $402.2M |
| Research and development | $451.4M+13.7% | $397.1M-28.6% | $555.9M-35.1% | $856.8M-6.0% | $911.9M |
| Sales and marketing | $875.1M+10.9% | $789.0M+64.0% | $481.0M-9.5% | $531.5M+29.2% | $411.4M |
| General and administrative | $1.00B+6.9% | $937.3M+7.6% | $871.1M-32.3% | $1.29B+40.5% | $915.6M |
| Total costs and expenses | $6.50B+10.2% | $5.90B+21.0% | $4.88B-12.2% | $5.55B+27.9% | $4.34B |
| Loss from operations | -$188.4M-58.4% | -$118.9M+75.0% | -$475.6M+67.4% | -$1.46B-28.5% | -$1.14B |
| Interest expense | -$20.8M+28.2% | -$28.9M-10.3% | -$26.2M-32.9% | -$19.7M+61.8% | -$51.6M |
| Other income, net | $155.9M-10.0% | $173.2M+1.8% | $170.1M+270.1% | -$100.0M-173.6% | $135.9M |
| (Loss) income before income taxes | -$53.2M-310.0% | $25.4M+107.6% | -$331.7M+79.0% | -$1.58B-50.2% | -$1.05B |
| (Benefit from) provision for income taxes | -$2.90B-113009.4% | $2.6M-70.2% | $8.6M+46.7% | $5.9M-47.7% | $11.2M |
| Net income (loss) | $2.84B+12382.5% | $22.8M+106.7% | -$340.3M+78.5% | -$1.58B-49.2% | -$1.06B |
| Basic (in dollars per share) | $6920.00+11433.3% | $60.00+106.8% | -$880.00+80.3% | -$4470.00-41.0% | -$3170.00 |
| Diluted (in dollars per share) | $6810.00+11250.0% | $60.00+106.8% | -$880.00+80.3% | -$4470.00-41.0% | -$3170.00 |
| Basic (in shares) | 410.8M+0.4% | 409.2M+6.2% | 385.3M+8.6% | 354.7M+6.0% | 334.7M |
| Diluted (in shares) | 417.7M+1.0% | 413.7M+7.3% | 385.3M+8.6% | 354.7M+6.0% | 334.7M |
| Cost of revenue | |||||
| Stock-based compensation included in costs and expenses | $135.5M-16.6% | $162.5M-16.7% | $195.1M-18.5% | $239.3M | — |
| Operations and support | |||||
| Research and development | |||||
| Sales and marketing | |||||
| General and administrative | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.